GSK Plc (GSK)
47.28
-1.20
(-2.47%)
USD |
NYSE |
Dec 09, 16:00
47.37
+0.10
(+0.20%)
After-Hours: 17:16
GSK Market Cap: 95.00B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 278.47B |
| Biodexa Pharmaceuticals Plc | 2.524M |
| NuCana Plc | 17.98M |
| Autolus Therapeutics Plc | 400.55M |
| Bicycle Therapeutics Plc | 492.51M |
Market Cap Related Metrics
| PE Ratio | 13.48 |
| PS Ratio | 2.317 |
| PEG Ratio | 0.1052 |
| Price to Book Value | 4.370 |
| Price to Free Cash Flow | 17.27 |
| Price | 47.28 |
| Earnings Yield | 7.42% |
| PEGY Ratio | 0.1025 |
| Operating PE Ratio | 9.864 |
| Normalized PE Ratio | 11.92 |